# FDA Inspection 1221183 - Astellas Pharma Inc. - October 27, 2023

Source: https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/7b2bb798-3d18-402e-a63a-d407730fcaa3
Source feed: FDA_Inspections

> FDA Inspection 1221183 for Astellas Pharma Inc. on October 27, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221183
- Company Name: Astellas Pharma Inc.
- Inspection Date: 2023-10-27
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 963366 - 2016-03-07](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/18c69256-8b1e-4f8e-9d3b-c6feb02a916e)

Company: https://www.keypedia.com/companies/astellas-pharma-inc/b0bdaca5-537e-4e43-9609-7ae4702f2f86

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c